{
    "eid": "2-s2.0-85039863241",
    "title": "Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis",
    "cover-date": "2018-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Depression",
        "Desipramine",
        "Immune function",
        "Inflammation",
        "Lofepramine",
        "Multiple sclerosis",
        "Oxidative and nitrosative stress"
    ],
    "authors": [
        "Gerwyn Morris",
        "Edna Maria Vissoci Reiche",
        "Andrea Murru",
        "Andr\u00e9 F. Carvalho",
        "Michael Maes",
        "Michael Berk",
        "Basant K. Puri"
    ],
    "citedby-count": 46,
    "ref-count": 316,
    "ref-list": [
        "Multiple sclerosis normal-appearing white matter: pathology-imaging correlations",
        "The good and the bad of neuroinflammation in multiple sclerosis",
        "Neuronal injury in chronic CNS inflammation",
        "The link between multiple sclerosis and depression",
        "Recommendations for observational studies of comorbidity in multiple sclerosis",
        "A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview",
        "Neuropsychological aspects of multiple sclerosis: a quantitative review",
        "Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis",
        "Cognitive dysfunction in multiple sclerosis: a review of recent developments",
        "Depression in multiple sclerosis: relationship to planning ability",
        "Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis",
        "Multiple sclerosis and suicide",
        "Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression",
        "The epidemiology of depression across cultures",
        "Multiple sclerosis and depression",
        "Neuroinflammation, Neurodegeneration and Depression",
        "Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways",
        "Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses",
        "A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior",
        "The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders",
        "Immune-inflammatory and oxidative and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis: Increased peripheral inflammation but less acute neuroinflammation",
        "Oxidative & nitrosative stress in depression: why so much stress?",
        "Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis",
        "Absolute number and percentage of circulating natural killer, non-MHC-restricted T cytotoxic, and phagocytic cells in unipolar depression",
        "Multiple sclerosis and regulatory T cells",
        "Abnormalities in regulatory T cells and natural killer cells in major depressive disorder",
        "Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications",
        "Depression and immunity: a role for T cells?",
        "Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells",
        "MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines",
        "Epigenetics of multiple sclerosis: an updated review",
        "The heterogeneity of \u201cmajor depression",
        "Heterogeneity versus homogeneity of multiple sclerosis",
        "Vascular pathology in multiple sclerosis: Reframing pathogenesis around the blood-brain barrier",
        "Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment",
        "Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis",
        "Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale",
        "Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosis",
        "Peripheral oxidative stress in relapsing-remitting multiple sclerosis",
        "Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis",
        "Immunology and oxidative stress in multiple sclerosis: clinical and basic approach",
        "Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis",
        "Oxidative modification of patient\u2019s plasma proteins and its role in pathogenesis of multiple sclerosis",
        "Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels",
        "Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients",
        "The potential role of nitric oxide in multiple sclerosis",
        "Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis",
        "New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors",
        "IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology",
        "Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications",
        "Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment",
        "Increased serum levels of 8-hydroxy-2\u2032-deoxyguanosine in clinical depression",
        "Elevated level of DNA damage and impaired repair of oxidative DNA damage in patients with recurrent depressive disorder",
        "Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness",
        "Lipid peroxidation and depressed mood in community-dwelling older men and women",
        "Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids",
        "Depression and oxidative damage to lipids",
        "The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases",
        "The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial",
        "Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised. Placebo Controlled Trial",
        "Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression",
        "The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence",
        "Mitochondrial dysfunction, oxidative stress, and major depressive disorder",
        "The psychiatric manifestations of mitochondrial cytopathies: a clinical and MR spectroscopy investigation",
        "Serum total antioxidant capacity in patients with multiple sclerosis",
        "Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis",
        "Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction",
        "Glutathione in multiple sclerosis: more than just an antioxidant?",
        "Glutathione in multiple sclerosis",
        "Redox regulation of cellular stress response in multiple sclerosis",
        "Increased microglial catalase activity in multiple sclerosis grey matter",
        "Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression",
        "Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes",
        "Red blood cell superoxide dismutase and catalase activities in patients suffering from multiple sclerosis treated with adrenocorticotropic hormone",
        "Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology",
        "Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions",
        "Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2",
        "Effects of dimethyl fumarate on neuroprotection and immunomodulation",
        "Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy",
        "Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes",
        "Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis",
        "Unmedicated, remitted patients with major depression have decreased serum immunoglobulin A",
        "Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis",
        "Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS)",
        "[Extending therapeutic possibilities in relapsing-remitting multiple sclerosis: dimethyl fumarate]",
        "MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis",
        "Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial",
        "Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis",
        "The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling: new drug targets in neuroimmune disorders",
        "Polyunsaturated fatty acids as antioxidants",
        "A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness",
        "Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment",
        "Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts",
        "Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders",
        "Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia",
        "Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression",
        "Thioredoxin is not a marker for treatment-resistance depression but associated with cognitive function: An rTMS study",
        "Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder",
        "Increased serum Cu/Zn SOD in individuals with clinical depression normalizes after zinc and anti-oxidant therapy",
        "Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment",
        "Nrf2 participates in depressive disorders through an anti-inflammatory mechanism",
        "Exogenous antioxidants\u2014double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses",
        "Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression",
        "Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression",
        "Role of antioxidants in generalised anxiety disorder and depression",
        "EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials",
        "N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis",
        "Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study",
        "Natural polyphenols in the management of major depression",
        "Cytokines and the pathogenesis of multiple sclerosis",
        "Plasma biomarkers discriminate clinical forms of multiple sclerosis",
        "Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay",
        "Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis",
        "Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations",
        "Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis",
        "Cytokine mRNA expression in patients with multiple sclerosis and fatigue",
        "Genetic, immune-inflammatory, and oxidative stress biomarkers as predictors for disability and disease progression in multiple sclerosis",
        "Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients",
        "Psychological stress and cytokine production in multiple sclerosis: correlation with disease symptomatology",
        "Interleukin-1beta causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53",
        "Cerebrospinal fluid IL-1beta correlates with cortical pathology load in multiple sclerosis at clinical onset",
        "Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-beta",
        "The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels",
        "Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis",
        "IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production",
        "NLRP3 inflammasome is associated with the response to IFN-beta in patients with multiple sclerosis",
        "TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab",
        "So depression is an inflammatory disease, but where does the inflammation come from?",
        "Evidence for a systemic immune activation during depression: Results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining",
        "Evidence for an immune response in major depression: a review and hypothesis",
        "A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness",
        "Depression\u2019s multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways",
        "Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression",
        "A meta-analysis of cytokines in major depression",
        "A review of the relationship between proinflammatory cytokines and major depressive disorder",
        "The inflammasome: pathways linking psychological stress, depression, and systemic illnesses",
        "The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression",
        "The toll-like receptor radical cycle pathway: a new drug target in immune-related chronic fatigue",
        "Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment",
        "Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death",
        "Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics",
        "A neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome",
        "Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation",
        "Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies",
        "Increased PK11195 PET binding in the cortex of patients with MS correlates with disability",
        "Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study",
        "Macrophage subsets and microglia in multiple sclerosis",
        "Increased uric acid levels in bipolar disorder subjects during different phases of illness",
        "Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS)",
        "Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia",
        "Implicating MicroRNAs as regulators of microglia and astrocyte responses in human CNS inflammatory disease (P5.018)",
        "Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells",
        "TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model",
        "The relationship between bipolar disorder and biological rhythms",
        "T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases",
        "Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases",
        "Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation",
        "The role of white matter abnormalities in treatment-resistant depression: a systematic review",
        "Microglial dysfunction connects depression and Alzheimer\u2019s disease",
        "Reshef R Depression as a microglial disease",
        "Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission",
        "Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis",
        "Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial",
        "Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial",
        "Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder",
        "The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis",
        "Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis",
        "NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury",
        "Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management",
        "Reduced expression of PGC-1alpha partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex",
        "Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis",
        "Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients",
        "Review: mitochondria and disease progression in multiple sclerosis",
        "Mitochondrial changes within axons in multiple sclerosis",
        "Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis",
        "High-resolution 1 H NMR spectroscopy reveals differences in CSF metabolic profiles for MS patients with inflammatory vs. non-inflammatory plaques",
        "Cerebrospinal fluid ATP metabolites in multiple sclerosis",
        "Adenosine triphosphate metabolism measured by phosphorus magnetic resonance spectroscopy: a potential biomarker for multiple sclerosis severity",
        "In vivo MR spectroscopy in diagnosis and research of neuropsychiatric disorders",
        "Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy",
        "Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent N -acetylaspartate",
        "Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders",
        "Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems",
        "A mitochondrial bioenergetic basis of depression",
        "PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review",
        "Renshaw PF Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder",
        "Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness",
        "Affective disorders, antidepressant drugs and brain metabolism",
        "Mitochondrial respiration in blood platelets of depressive patients",
        "So depression is an inflammatory disease, but where does the inflammation come from?",
        "Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients",
        "Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression",
        "Suivi immunobiologique de malades atteints de scl\u00e9rose en plaques",
        "Detection of the specific IgM and IgA circulating in sera of multiple sclerosis patients: interest and perspectives",
        "Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters",
        "Specific microbiota direct the differentiation of Th17 cells in the mucosa of the small intestine",
        "Role of the gut microbiota in the development and function of lymphoid cells",
        "The effects of the microbiota on the host immune system",
        "Gut microbiome and the risk factors in central nervous system autoimmunity",
        "Digesting the emerging role for the gut microbiome in central nervous system demyelination",
        "Unraveling the relationship between microbial translocation and systemic immune activation in HIV infection",
        "Microbial view of central nervous system autoimmunity",
        "Autoimmune host-microbiota interactions at barrier sites and beyond",
        "Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability",
        "Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases",
        "Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells",
        "The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression",
        "In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes",
        "The role of microbiome in central nervous system disorders",
        "From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways",
        "Altered fecal microbiota composition in patients with major depressive disorder",
        "Gut-brain axis: how the microbiome influences anxiety and depression",
        "Microbiota regulation of the Mammalian gut-brain axis",
        "The impact of microbiota on brain and behavior: mechanisms & therapeutic potential",
        "IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells",
        "Altered T Lymphocyte proliferation upon lipopolysaccharide challenge ex vivo",
        "Autoimmunity and the Gut",
        "Origin and consequences of brain toll-like receptor 4 pathway stimulation in an experimental model of depression",
        "Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis",
        "Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration",
        "Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis",
        "Beck depression inventory factors related to demyelinating lesions of the left arcuate fasciculus region",
        "Brain MRI lesions and atrophy are related to depression in multiple sclerosis",
        "Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects",
        "Depressive symptoms and MRI changes in multiple sclerosis",
        "Structural brain abnormalities in multiple sclerosis patients with major depression",
        "Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms",
        "Decreased hippocampal volume, indirectly measured, is associated with depressive symptoms and consolidation deficits in multiple sclerosis",
        "Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling",
        "The relationship between mercury and autism: a comprehensive review and discussion",
        "Hippocampal neuroplasticity and inflammation: relevance for multiple sclerosis",
        "Lower hippocampal volume in patients suffering from depression: a meta-analysis",
        "Changes of brain morphometry in first-episode, drug-naive, non-late-life adult patients with major depression: an optimized voxel-based morphometry study",
        "Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies",
        "Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis",
        "Texture analysis of T2-weighted MR images to assess acute inflammation in brain MS lesions",
        "Inflammation, demyelination, and degeneration\u2014recent insights from MS pathology",
        "The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA",
        "Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration",
        "Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter",
        "Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders",
        "Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis",
        "Extensive hippocampal demyelination in multiple sclerosis",
        "Hypothalamic\u2013pituitary\u2013adrenal axis dysfunction in chronic fatigue syndrome",
        "Regional hippocampal atrophy in multiple sclerosis",
        "Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients",
        "Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression",
        "Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function",
        "Adrenal size is increased in multiple sclerosis",
        "The neuroendocrine axis in patients with multiple sclerosis",
        "Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis",
        "Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis",
        "Lesion pattern in patients with multiple sclerosis and depression",
        "Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation",
        "Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis",
        "Neuroendocrine immunoregulation in multiple sclerosis",
        "Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis",
        "Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions",
        "Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression",
        "Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis",
        "Cortisol awakening response is linked to disease course and progression in multiple sclerosis",
        "Is there an association between the expanded disability status scale and inflammatory markers in multiple sclerosis?",
        "The cortisol awakening response and major depression: examining the evidence",
        "Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: Results from a large cohort study",
        "Major depression in young girls is related to altered cortisol awakening response",
        "Cortisol secretion in depressed, and at-risk adults",
        "Increased salivary cortisol after waking in depression",
        "Increase in concentration of waking salivary cortisol in recovered patients with depression",
        "The cortisol awakening response in patients remitted from depression",
        "Hypothalamic-pituitary-adrenal axis activity in older persons with and without a depressive disorder",
        "The self-perceived symptom distress and health-related conditions associated with morning to evening diurnal cortisol patterns in outpatients with major depressive disorder",
        "Basal cortisol levels in relation to dimensions and DSM-IV categories of depression and anxiety",
        "Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis",
        "Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis",
        "Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production",
        "Mechanistic insights into corticosteroids in multiple sclerosis: war horse or chameleon?",
        "Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex",
        "Suppressive effect of glucocorticoids on TNF-alpha production is associated with their clinical effect in multiple sclerosis",
        "Treatment of acute relapses in multiple sclerosis",
        "Uitdehaag BMJ Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS",
        "Huitinga I Glucocorticoid receptor haplotypes conferring increased sensitivity (<em>Bcl</em>I and N363S) are associated with faster progression of multiple sclerosis",
        "Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients",
        "Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative \u03b2 isoform: a mechanism for the generation of glucocorticoid resistance",
        "Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells",
        "Cytokines sing the blues: inflammation and the pathogenesis of depression",
        "Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation",
        "Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment",
        "Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder",
        "GILZ: glitzing up our understanding of the glucocorticoid receptor in psychopathology",
        "Glucocorticoid receptor isoforms alpha and beta in in vitro cytokine-induced glucocorticoid insensitivity",
        "Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression",
        "Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system",
        "Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression",
        "Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk",
        "A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling",
        "From stress to inflammation and major depressive disorder: a social signal transduction theory of depression",
        "Altered glucocorticoid immunoregulation in treatment resistant depression",
        "Immunity and cognition: what do age-related dementia, HIV-dementia and \u2018chemo-brain\u2019 have in common?",
        "CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis",
        "Clinical trial of a new antidepressant (desipramine hydrochloride) in a hospital setting",
        "Antidepressant effects of desipramine administered in two dosage schedules",
        "Concentrations plasmatiques de l'imipramine et de la desmethylimipramine et effet anti-depresseur au cours d'un traitement control",
        "Clinical implications of imipramine plasma levels for depressive illness",
        "Imipramine: Clinical effects and pharmacokinetic variability",
        "Tricyclic antidepressants",
        "Do desipramine [10,11-Dihydro-5-[3-(methylamino) propyl]-5H\u2013dibenz[b,f]azepine monohydrochloride] and Fluoxetine [N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-propan-1-amine] ameliorate the extent of colonic damage induced by acetic acid in rats?",
        "Catalase, superoxide dismutase and glutathione peroxidase activity in neutrophils of sham-operated and olfactory-bulbectomised rats following chronic treatment with desipramine and lithium chloride",
        "Protective effects of antidepressants against chronic fatigue syndrome - induced behavioral changes and biochemical alterations",
        "Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: possible involvement of NO\u2013cGMP pathway",
        "Effects of desipramine on the antioxidant status in rat tissues at carrageenan-induced paw inflammation",
        "Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection",
        "Effects of stress on neurotrophic factor expression in the rat brain",
        "Treatment of multiple sclerosis with lofepramine, l-phenylalanine and vitamin B12: mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems",
        "A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the \u201cCari Loder regime\u201d) in the treatment of multiple sclerosis",
        "Two methods for semi-automated quantification of changes in ventricular volume and their use in schizophrenia",
        "MRI changes in multiple sclerosis following treatment with lofepramine and l-phenylalanine"
    ],
    "affiliation": [
        {
            "affiliation-city": "Londrina",
            "@id": "60027866",
            "affilname": "Universidade Estadual de Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027866",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60026553",
            "affilname": "University of Melbourne",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Fortaleza",
            "@id": "60020457",
            "affilname": "Universidade Federal do Cear\u00e1",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020457",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "London",
            "@id": "60020416",
            "affilname": "Hammersmith Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020416",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "60010814",
            "affilname": "Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer - IDIBAPS",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010814",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Waalre",
            "@id": "116324567",
            "affilname": "Revitalis",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116324567",
            "affiliation-country": "Netherlands"
        }
    ],
    "funding": [
        "National Health and Medical Research Council"
    ]
}